Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.

about

Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results.

P2860

Q48136899-5456E70F-0E3C-4EA3-A1D7-75194E3447EB

P2860

Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.

Item

http://www.wikidata.org/entity/Q40146584

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of the 21-gene recurren ...... bular carcinoma of the breast.

@en

type

Item

label

Impact of the 21-gene recurren ...... bular carcinoma of the breast.

@en

prefLabel

Impact of the 21-gene recurren ...... bular carcinoma of the breast.

@en

P1476

Impact of the 21-gene recurren ...... obular carcinoma of the breast

@en

P2093

Jing Li Huang

http://www.w3.org/2001/XMLSchema#string

Schelomo Marmor

http://www.w3.org/2001/XMLSchema#string

Scott Kizy

http://www.w3.org/2001/XMLSchema#string

Todd M Tuttle

http://www.w3.org/2001/XMLSchema#string

P2860

Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

Breast cancer.

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers.

Multigene prognostic tests in breast cancer: past, present, future

P2888

s10549-017-4355-9

P304

757-763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-017-4355-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

J Hui

P577

2017-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086154384

http://www.w3.org/2001/XMLSchema#string

P698

28647915

http://www.w3.org/2001/XMLSchema#string

Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.

about

P2860

P2860

Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698